Patent 9011819 was granted and assigned to Targeson Inc on April, 2015 by the United States Patent and Trademark Office.
The present invention generally relates to microbubble contrast agent compositions which are detectable by optical imaging methods, such as fluorescence, near-infrared or bioluminescence. Uses of the described compositions for imaging and therapeutic applications are contemplated.